HuBIE: The human blood immunome encyclopedia of TCRs and BCRs in bloodstream infections and cancer - Summary - MDSpire

HuBIE: The human blood immunome encyclopedia of TCRs and BCRs in bloodstream infections and cancer

  • By

  • Vahid Akbari

  • Alexandra Morgan

  • Michie Yasuda

  • Ulrich Schlecht

  • Sylvie McNamara

  • Hosseinali Asgharian

  • Christopher Tam

  • Rena Adachi

  • Elisa Contreras

  • Zhipei Gracie Du

  • Sandra Siemann

  • Hahn Zhao

  • Jeyashree Ashok Balasubramanian

  • Diane Balallo

  • Devanshee Sanghvi

  • Tarini Shankar

  • Sanjucta Dutta

  • Stefan Riedel

  • Stefanie Mattson

  • Daniel Burukhin

  • Florian Rubelt

  • Sowmi Utiramerur

  • Dinesh Kumar

  • Hamid Mirebrahim

  • Ramy Arnaout

  • June 18, 2026

  • 0 min

Share

Objective:

To introduce the Human Blood Immunome Encyclopedia (HuBIE), a large-scale collection of TCR and BCR repertoires aimed at enhancing understanding of immune responses in cancer and bloodstream infections, ultimately improving patient outcomes.

Approach:
    Key Findings:
    • Significant differences in TRB and IGH composition across ethnic groups, suggesting the need for tailored immunotherapies.
    • Age-related decline in repertoire diversity follows distinct patterns for TRB, TRD, and IGH, indicating potential biomarkers for aging.
    • Greater immunological diversity is associated with improved survival for elderly participants, highlighting the importance of immune health in aging.
    Interpretation:

    HuBIE serves as a valuable resource for the immune-repertoire community, facilitating the mapping of the human immunome.

    Limitations:
    • Potential biases due to sample processing and cohort selection, which may affect the generalizability of findings.
    • Limited to blood-derived samples, which may not represent all immune responses, particularly in tissues.
    Conclusion:

    HuBIE provides a comprehensive dataset for advancing diagnostics, prognostic markers, and therapeutic strategies in immunology, paving the way for personalized medicine.

Original Source(s)

Related Content